Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1193-22-2 | MDL No. : | MFCD00051502 |
Formula : | C4H5N3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HFMLLTVIMFEQRE-UHFFFAOYSA-N |
M.W : | 111.10 | Pubchem ID : | 135431272 |
Synonyms : |
|
Num. heavy atoms : | 8 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 29.26 |
TPSA : | 71.77 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.82 cm/s |
Log Po/w (iLOGP) : | 0.13 |
Log Po/w (XLOGP3) : | -1.18 |
Log Po/w (WLOGP) : | -0.64 |
Log Po/w (MLOGP) : | -1.26 |
Log Po/w (SILICOS-IT) : | 0.49 |
Consensus Log Po/w : | -0.49 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.34 |
Solubility : | 50.7 mg/ml ; 0.457 mol/l |
Class : | Very soluble |
Log S (Ali) : | 0.17 |
Solubility : | 163.0 mg/ml ; 1.47 mol/l |
Class : | Highly soluble |
Log S (SILICOS-IT) : | -1.14 |
Solubility : | 8.07 mg/ml ; 0.0726 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.52 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98.4% | With ammonia; nickel; titanium(IV) oxide In water at 90℃; for 5 h; | Step two, the above 2-mercapto-4-amino-6-hydroxypyridine was added to aqueous ammonia, 2-mercapto-4-amino-6-hydroxypyridine and the mass ratio of 1:15 ammonia, the ammonia concentration was 25 percent, and then adding the active nickel and titanium oxide, 2-mercapto-4-amino-6-hydroxypyridine, activated nickel, titanium dioxide molar ratio of these three is 1: 4: 1.5, was heated to 90 deg.] C, refluxed for 5 hours, then take advantage of The active nickel and titanium dioxide were removed by hot filtration, cooled to room temperature, and a solid precipitated. The solid was washed with 30 ml of water and dried at 40 ° C to give 4-amino-6-hydroxypyrimidine in a yield of 98.4percent |
64.4% | Reflux | 4-Amino-6-hydroxy-2-sulfanylpyrimidine (20 g) in boiling ethanol (300 mL) was treated under stirring with Raney-Ni until the starting material disappeared. The supension was filtered while hot, the precipitate washed with hot ethanol(300 mL) and the filtrate evaporated to dryness. The residue afforded on crystallization from ethanol (ether added toturbidity) 4-amino-6-hydroxypyrimidine, m.p. 272°C. Yield, 10.0 g (64.4percent). For C4H5N3O (111.10) calculated 43.24percentC,4.54percentH, 37.82percentN; found 43.40percentC, 4.65percentH, 38.01percentN. Mass spectrum: 112 (MH+). 1H-NMR (CD3SOCD3): 4.97 s, 1H(H-5); 6.42 brs, 2H (NH2); 7.77 s, 1H (H-2); 11.41 brs, 1H (OH). |
[ 1672-50-0 ]
4,5-Diamino-6-hydroxypyrimidine
Similarity: 0.80
[ 3977-29-5 ]
2-Amino-6-methylpyrimidin-4(1H)-one
Similarity: 0.71
[ 3993-79-1 ]
2-Amino-5-iodopyrimidin-4(1H)-one
Similarity: 0.68
[ 3680-71-5 ]
1,7-Dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one
Similarity: 0.68
[ 1672-50-0 ]
4,5-Diamino-6-hydroxypyrimidine
Similarity: 0.80
[ 3977-29-5 ]
2-Amino-6-methylpyrimidin-4(1H)-one
Similarity: 0.71
[ 3993-79-1 ]
2-Amino-5-iodopyrimidin-4(1H)-one
Similarity: 0.68
[ 6312-72-7 ]
2,6-Diamino-5-bromopyrimidin-4(1H)-one
Similarity: 0.68
[ 1672-50-0 ]
4,5-Diamino-6-hydroxypyrimidine
Similarity: 0.80
[ 3977-29-5 ]
2-Amino-6-methylpyrimidin-4(1H)-one
Similarity: 0.71
[ 3993-79-1 ]
2-Amino-5-iodopyrimidin-4(1H)-one
Similarity: 0.68
[ 6312-72-7 ]
2,6-Diamino-5-bromopyrimidin-4(1H)-one
Similarity: 0.68